Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Escherichia coli vaccine (Middle East for Vaccines)
- Development stage
- Unknown
- Lead developer
- MEVAC
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
The Escherichia coli vaccine produced by Middle East for Vaccines (MEVAC) is a veterinary biologic indicated for the immunization of poultry against infections caused by pathogenic *Escherichia coli* (colibacillosis). The vaccine is designed to stimulate the bird's immune system to recognize and neutralize *E. coli* antigens, thereby reducing mortality, lesion severity, and economic losses associated with respiratory tract infections, septicemia, and cellulitis in broiler and breeder flocks. As an inactivated bacterial vaccine (bacterin), it typically contains killed pathogenic strains that induce a protective antibody response without the risk of causing disease.
- Brand names
- MEVAC E. COLI
- Other names
- Escherichia coli VaccineE. coli vaccine (Poultry)
Beyond the preview
Go deeper on Escherichia coli vaccine (Middle East for Vaccines).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Escherichia coli vaccine (Middle East for Vaccines).